Position in SVRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,419,825
+$12,320,435 QoQ
Shares Held
17,600,621
0.0% QoQ
Ownership
8.57%
of shares outstanding
% of Portfolio
6.45%
of 13F equity value
Holder Rank
#2
of 181 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. SVRA ranks #3 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
This page
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in SVRA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,419,825 | 17,600,621 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $96,099,390 | 17,600,621 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $106,131,744 | 17,600,621 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $62,834,216 | 17,600,621 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,129,415 | 17,600,621 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $48,753,720 | 17,600,621 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,715,952 | 14,565,457 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,757,537 | 14,565,457 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,698,791 | 14,565,457 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $72,535,975 | 14,565,457 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $66,893,929 | 14,232,751 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $53,799,798 | 14,232,751 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $37,134,200 | 11,622,598 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,664,066 | 11,622,598 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,015,026 | 11,622,598 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,015,026 | 11,622,598 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,666,348 | 11,622,598 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,225,603 | 11,622,598 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $14,412,021 | 11,622,598 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,039,185 | 11,622,598 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,758,416 | 11,622,598 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,175,003 | 11,622,598 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,897,881 | 5,128,593 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,590,166 | 5,128,593 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $12,770,196 | 5,128,593 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $10,872,617 | 5,128,593 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||